Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pacifique Ndishimye has a total of 127 co-authors. Here are the top co-authors by number of shared publications:

  • Benjamin Hewins

    Laboratory of Emerging Infectious Diseases, Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Canada

    4 shared publications
  • Janvier Karuhije

    Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda

    4 shared publications
  • Carmen Monica Pop

    Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Romania

    3 shared publications
  • David Kelvin

    Laboratory of Emerging Infectious Diseases, Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Canada

    3 shared publications
  • Fathiah Zakham

    Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland

    3 shared publications
  • Gustavo S. Martinez

    Dalhousie University Faculty of Medicine

    3 shared publications

Latest Publications

  • Open Access

    Capacity building for genomic surveillance of mpox and other emerging diseases in resource-limited settings within the African Great Lakes region

    by Leonard Schuele, Néhémie Nzoyikorera, Jean Claude Udahemuka, Hayley Cassidy, Leandre Murhula Masirika, David F. Nieuwenhuijse, Cassien Nduwimana, Richard Molenkamp, Joseph Nyandwi, Marjan Boter, et al.

    Genomic surveillance has become an indispensable tool for the identification of pathogens and tracking of transmission chains. Building upon the global sequencing and surveillance infrastructure developed and expanded during the COVID-19 pandemic, these capacities are now being adapted to track other pathogens in low- and middle-income countries which remain disproportionately affected by infectious diseases. This is evident in the recent and unprecedented spread of mpox virus in regions experiencing multiple concurrent infectious disease outbreaks, highlighting the need for broad, adaptable diagnostic detection and sequencing capacity. In this Perspective, we describe the applications, insights, and challenges encountered during ongoing capacity building efforts for the characterization of the mpox outbreak and other emerging pathogens in the African Great Lakes Region.

  • Open Access

    Persistent circulation of Rift Valley fever virus lineage C in Rwanda, 2022–2025

    by Jean Claude Udahemuka, Hayley Cassidy, Leonard Schuele, Evodie Uwibambe, Methode Gasana Ngabo, Leandre Murhula Masirika, Saria Otani, Misbah Gashegu, Jean-Claude Twizere, Frank Aarestrup, et al.

    Rwanda has experienced recurrent Rift Valley fever virus outbreaks in the last decade. In this study, we investigated whether these outbreaks resulted from repeated introductions or sustained local circulation. We generated RVFV whole-genome sequences from livestock samples collected between 2022 and 2025 using Nanopore sequencing. Genomic analyses indicated the outbreaks resulted from sustained local circulation of lineage C rather than repeated introductions, suggesting ongoing transmission likely driven by sporadic spillover. This study underscores the importance of continuous genomic surveillance in endemic settings.

  • Open Access

    The Trans-Kingdom Spectrum of Mpox-like Lesion Pustules of Suspect Patients in the Mpox Clade Ib Outbreak in Eastern Democratic Republic of the Congo

    by Leandre Murhula Masirika, Benjamin Hewins, Ali Toloue Ostadgavahi, Mansi Dutt, Léandre Mutimbwa Mambo, Jean Claude Udahemuka, Pacifique Ndishimye, Justin Bengehya Mbiribindi, Freddy Belesi Siangoli, Patricia Kelvin, et al.

    During infectious disease outbreaks, acquiring genetic data across various kingdoms offers essential information to tailor precise treatment methodologies and bolster clinical, epidemiological, and public health awareness. Metagenomics sequencing has paved the way for personalized treatment approaches and streamlined the monitoring process for both co-infections and opportunistic infections. In this study, we conducted long-read metagenomic DNA sequencing on mpox-like lesion pustules from six suspected patients who were positive and confirmed to be infected with MPXV during the MPXV subclade Ib outbreak in the Eastern Democratic Republic of the Congo. The sequenced data were taxonomically classified as bacterial, fungal, and viral in composition. Our results show a wide spectrum of microorganisms present in the lesions. Bacteria such as Corynebacterium amycolatum, Gardnerella vaginalis, Enterococcus faecium, Enterobacter clocae, Staphylococcus epidermidis, and Stenotrophomonas maltophilia were found in the lesions. The viral classification of the reads pointed out the absolute predominance of the monkeypox virus. Taken together, the outcomes of this investigation underscore the potential involvement of microorganisms in mpox lesions and the possible role that co-infections played in exacerbating disease severity and transmission during the MPXV subclade Ib outbreak.


  • Open Access

    Serological evidence supports the transmission of clade Ib mpox virus by professional sex workers and spread within households in South Kivu, DRC

    by Leandre Murhula Masirika, Luca M. Zaeck, Pacifique Ndishimye, Jean Claude Udahemuka, Saria Otani, Frank M. Aarestrup, Leonard Schuele, Babs E. Verstrepen, Corine H. GeurtsvanKessel, Jean Pierre Musabyimana, et al.

    Understanding secondary attack rates is a key knowledge gap in the ongoing clade Ib mpox virus (MPXV) outbreak in the Democratic Republic of the Congo. Here, we report the first serological study to investigate the extent of local MPXV clade Ib transmission, performed in South Kivu, DRC. Sera were collected in November and December 2023 (n=120), and May 2024 (n=48) from professional sex workers (PSW) and visitors of 25 bars with reports of mpox cases. In 18% and 17% of these sera, respectively, serological evidence for MPXV infection was detected, indicating that PSW played an important role in MPXV clade Ib transmission in this region. Additionally, sera from 108 direct contacts of mpox cases from 34 households were collected between September 2023 and May 2024. At least one serum sample tested seropositive in 50% of households. Serological studies are needed to comprehend the extent and severity of the ongoing MPXV outbreak, and may be used to guide targeted vaccination strategies, particularly for high-risk groups.

  • Antioxidant capacity, acute and sub-acute oral toxicity, and in vivo anti-inflammatory effects of Tetradenia riparia hydroalcoholic extract

    by Martin Ndayambaje, Thierry Habyarimana, Hicham Wahnou, Aimable Nsanzurwimo, Oumaima Chgari, Pacifique Ndishimye, Asmaa Mezty, Mernissi Farida, Mehdi Karkouri, Younes Zaid, et al.

    Tetradenia riparia (T. riparia) is a medicinal plant native to sub-Saharan Africa, traditionally used but has limited in vivo scientific validation. This study evaluated its antioxidant, toxicity, and anti-inflammatory effects using in vivo toxicity tests, paw edema, air pouch models, and vascular permeability assessment. Additionally, qualitative phytochemical analysis and quantitative measurements of total polyphenolic and flavonoid content were conducted. In vitro assays revealed significant concentrations of polyphenolic and flavonoid compounds, demonstrating notable radical scavenging activities in DPPH, phosphomolybdate, and FRAP assays. In vivo studies demonstrated that T. riparia extract showed no indications of acute or sub-acute oral toxicity, even when administered at the highest tested dosage of 5000 mg/kg body weight (LD50 > 5000 mg/kg). Toxicity assessments confirmed its safety, showing no fatalities, significant organ damage as evidenced by histopathological analysis, or substantial adverse effects on most hematological and biochemical parameters. The hydroalcoholic extract of T. riparia demonstrated a notable anti-inflammatory effect that increased with dosage. The inhibition percentage of paw edema by the extract was high at 3 hours, reaching 39.13 ± 8.78%. Nitric oxide (NO) inhibition at doses of 0.5 g/kg and 1 g/kg was recorded as 36.09 ± 2.13% and 49.96 ± 5.41%, respectively. Regarding vascular permeability, T. riparia extract significantly reduced dye leakage (p < 0.05 and p < 0.001), with inhibition percentages of 61.57% and 75.25% at doses of 0.5 g/kg and 1 g/kg, respectively. These findings highlight its promising potential as a treatment for inflammatory disorders. In conclusion, phytochemical analysis identified compounds, which are believed to be responsible for the pharmacological effects observed. Further studies are needed to investigate the chronic consumption of hydroalcoholic extract for long-term isolate bioactive compounds, understand their mechanisms, ensure comprehensive safety profiles for potential drug development, and elucidate their anti-inflammatory mechanism.


  • Open Access

    Feasibility, Acceptability, Satisfaction, and Challenges of an mHealth App (e-ASCov) for Community-Based COVID-19 Screening by Community Health Workers in Rwanda: Mixed Methods Study

    by Abdou Y Omorou, Pacifique Ndishimye, Bruno Hoen, Léon Mutesa, Prosper Karame, Ladislas Nshimiyimana, Simon Galmiche, Hassan Mugabo, Janvier Murayire, Muco Mugisha, et al.

    Background: Although at the base of the pyramid-shaped organization of the Rwandan health system, community health workers (CHWs) are central to the community-based management of disease outbreaks. Objective: This mixed methods study aimed to explore the feasibility, acceptability, satisfaction, and challenges of a mobile health (mHealth) tool for community-based COVID-19 screening in Rwanda. Methods: Two urban (Gasabo and Nyarugenge) and 2 rural (Rusizi and Kirehe) districts in Rwanda participated in the project (smartphone app for COVID-19 screening). A mixed methods approach was used to inform the feasibility (awareness and expectation), acceptability (use and perceived benefits), satisfaction, and challenges of the mHealth intervention. At the end of the project, CHWs were asked to complete a quantitative questionnaire on the use of and satisfaction with the app. Then, in-depth interviews and focus group discussions were organized with CHWs. A content analysis was performed on the transcripts. Results: Overall, 383 CHWs were recruited and trained; 378 CHWs participated in the study. The mean age of CHWs was 36.7 (SD 6.6) to 45.3 (SD 9.9) years and most were women (237/378, 62.7%). More than 7000 people were registered with the use of the app and 20% were referred to a local COVID-19 testing facility. According to CHW reporting, the median number of people screened by each CHW ranged from 152 (IQR 70-276) for Nyarugenge to 24 (IQR 16-90) for Rusizi. COVID-19 positivity rates were higher in urban than rural districts: more than half of the CHWs in Gasabo reported a confirmed positive case versus only 2.4% for Kirehe and 15.4% for Rusizi. Despite the app being a novel tool, CHWs were well aware of the use of such a tool and had appropriate expectations. Acceptability and satisfaction were very high, with differences between urban and rural districts. Satisfaction was higher in Nyarugenge (72.8/100) and Gasabo (80.7/100) than in Kirehe (61.6/100) and Rusizi (64.5/100). More than 80% of the CHWs were willing to continue using the e-ASCov app, with the exception of CHWs in Kirehe (56.7%). The app was perceived as a tool to generate information on COVID-19, inform on the status of the pandemic, and help curb the spread of the pandemic in Rwanda. CHWs were satisfied with the app at all stages of its implementation in their districts. Conclusions: In this proof-of-concept study, a smartphone app for screening COVID-19 was useful as an mHealth tool to be used by CHWs, with the potential to increase health system efficiency in an epidemic context. The context should be analyzed for generalization on a country-wide scale, both in case of an epidemic and to take into account certain conditions at the community level. Information is needed on the conditions of generalization and transferability of this type of app to other health conditions so that CHWs can be given their full place in a pyramidal health system.


  • Open Access

    Understanding knowledge, attitudes and practices on Ebola Virus Disease: a multi-site mixed methods survey on preparedness in Rwanda

    by Janvier Karuhije, Menelas Nkeshimana, Fathiah Zakham, Benjamin Hewins, Justin Rutayisire, Gustavo Sganzerla Martinez, David Kelvin, Pacifique Ndishimye

    Background: The overall goal of this survey was to understand the knowledge, attitudes, and practices related to the Ebola Virus Disease (EVD) in Rwanda. Methods: This mixed-method cross-sectional survey was conducted in five selected districts of Rwanda. Quantitative data were collected from 1,010 participants using Kobo Collect Software and the analysis was performed using SPSS and Python software. Qualitative data were specifically collected from 98 participants through Key Informant Interviews (KIIs) and Focus Group Discussion (FGDs). Interview transcripts were imported into NVIVO 8 for coding and subsequent analysis. Results: As per our quantitative findings, we report that from the 1,010 respondents, 99.6% reported having previously heard of Ebola, 97.2% believed that vaccination is important in combatting the disease and 93.3% of individuals reported a willingness to receive vaccination should one become available. Around 54% of the respondents were correct in identifying that the disease is of a viral origin which originates from wild animals (42.1%). When asked if they believed that Rwanda is at risk of an EVD outbreak, 90% of the respondents believe that the country is at risk of an EVD outbreak, and the cofactors *gender* and *whether people dwell in Rubavu/Rusizi* were found to significantly impact their perception of threat. As per our qualitative findings, the respondents mentioned that both geographical proximity and relations with the Democratic Republic of Congo place Rwanda at risk of developing an internal outbreak. Although the respondents seemed to be aware of the Ebola prevention behaviours, it was noted that some of them will require significant time before reintegrating into the community an EVD survivor, as they will first need assurance that the patient has fully recovered. Therefore, the qualitative findings reinforce what we originally reported in the quantitative approach to this study. Conclusion: Our results show that there was high EVD-related knowledge and awareness among the general population in Rwanda. However, for strong public health awareness, preparedness, and protection, a massive investment should always be made in education about EVD with a special focus on districts neighboring countries where the disease is consistently being reported.


  • Open Access

    Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load

    by Cynthia L. Swan, Valentine Dushimiyimana, Pacifique Ndishimye, Rachelle Buchanan, Anthony Yourkowski, Sage Semafara, Sabin Nsanzimana, Magen E. Francis, Brittany Thivierge, Jocelyne Lew, et al.


  • Open Access

    Understanding Knowledge, Attitudes and Practices on Ebola Virus Disease: A Multi-Site Mixed Methods Survey on Preparedness in Rwanda

    by Janvier Karuhije, Menelas Nkeshimana, Fathiah Zakham, Benjamin Hewins, Justin Rutayisire, Gustavo S. Martinez, David J. Kelvin, Pacifique Ndishimye

    Background: The overall goal of this survey was to understand the Ebola Virus Disease (EVD) - related knowledge, attitudes, and practices in Rwanda. Methods: This cross-sectional mixed-methods survey was conducted in five selected districts: Rusizi, Karongi, Rubavu, Burera and Gasabo. Quantitative data was collected from 1,010 participants using a structured questionnaire and Kobo Collect. Qualitative data was collected from 98 participants through Key Informant Interviews and Focus Group Discussion using a semi structured interview guide. Results: Among the 1,010 surveyed respondents, 56% were male, 70.3% were married, and 50% had primary education. An important finding was the high level of Ebola awareness and knowledge in all the five districts, with 99.6% reporting having previously heard of Ebola, which indicates previous awareness-raising efforts were successful. More than 54% of respondents indicated that Ebola is caused by a virus which originates from wild animal animals (42.1%). Furthermore, fever (85%), bleeding (87.7), and vomiting (40.2%) were cited as the primary signs and symptoms for Ebola. Most of the respondents were knowledgeable regarding prevention measures for Ebola. Despite this, 80% of the survey respondents had not received formal training or health education on Ebola. Many respondents (90%) believe that the country is at risk of an EVD outbreak and about 87.8% think that they are personally at risk of contracting Ebola. Most respondents reported adopting habits that included avoiding physical contact with the patients and reducing unnecessary movements/travel throughout the Ebola-affected regions. Additionally, most respondents (97.2%) believed that it is important to be vaccinated to prevent Ebola, and around 93.3% were ready and willing to get vaccinated once the EVD vaccine is available. While the radio is the preferred source for Ebola-related information, the most trusted sources are the ministry of health and governmental institutions, such as the Rwanda Biomedical Centre. Conclusion: Our results show that there was high EVD-related knowledge and awareness among the general population in Rwanda. However, for strong public health awareness, preparedness, and protection, there is a need to implement public sensitization programmes that address EVD-related misconceptions and discriminatory attitudes toward EVD patients.

  • Open Access

    COVID-19 vaccination coverage and linkages with public willingness to receive vaccination prior to vaccine roll-out: Evidence from Rwanda

    by Pacifique Ndishimye, Gustavo S. Martinez, Benjamin Hewins, Ali Toloue Ostadgavahi, Anuj Kumar, Mansi Sharma, Janvier Karuhije, Menelas Nkeshimana, Sabin Nsanzimana, David Kelvin

    The rapid development of multiple SARS-CoV-2 vaccines within one year of the virus’s emergence is unprecedented and redefines the timeline for vaccine approval and rollout. Consequently, over 13 billion COVID-19 vaccine doses have been administered worldwide, accounting for ∼70% of the global population. Despite this steadfast scientific achievement, many inequalities exist in vaccine distribution and procurement, particularly in low- and middle-income countries such as those in Africa. This stems from the cost of COVID-19 vaccines, storage and cold-chain challenges, distribution to remote areas, proper personnel training, and so on. In addition to logistical challenges, many developed nations rapidly procured available vaccines, administering second and third doses and leaving many developing nations without the first dose. In this paper, we explore the level of reception to COVID-19 vaccines prior to their availability in Rwanda using a survey-based approach. While several countries reported spikes in vaccine hesitancy generally coinciding with new information, new policies, or newly reported vaccine risks, Rwanda functions as an exemplar for controlling disease burden and educating locals regarding the benefits of vaccination. We show that, even before COVID-19 vaccines were available, many Rwandans (97%) recognized the importance of COVID-19 vaccination and (93%) were willing to receive a COVID-19 vaccine following vaccine availability. Our results underscore the level of preparedness in Rwanda, which rivals and outcompetes many developed nations in terms of vaccination rate (nearing 80% in Rwanda), vaccine acceptance, and local knowledge relating to vaccination. Furthermore, in addition to the whole-of-government coordination as well as tailored delivery approach, previously developed practices relating to vaccination and communication surrounding the Ebola Virus Disease may have compounded the COVID-19 vaccine program in Rwanda, prior to its implementation.